Table 2.

Categorization of irAEs in Patient Cohort.

	n (%)	Grade of irAEs, n 1/2/3/4/5
Skin reaction	18 (40.9%)	14/1/3/0/0
Pneumonitis	10 (22.7%)	0/5/4/0/1
Infusion reaction	8 (18.2%)	5/3/0/0/0
Hepatitis	4 (9.1%)	2/0/1/1/0
Thyroid dysfunction	4 (9.1%)	4/0/0/0/0
Microhematuria	2 (4.5%)	2/0/0/0/0
Myocarditis	1 (2.3%)	0/0/0/1/0
Pancreatitis	1 (2.3%)	0/0/1/0/0
Enteritis	1 (2.3%)	0/1/0/0/0
Eye symptom	1 (2.3%)	1/0/0/0/0
Myositis/peripheral neuropathy	0 (0%)	0/0/0/0/0

irAE, immune-related adverse event; n, number